Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jun 22:10:29.
doi: 10.1186/1472-6882-10-29.

A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial

Catherine Cornu  1 , Laurent Remontet, Florence Noel-Baron, Alain Nicolas, Nathalie Feugier-Favier, Pascal Roy, Bruno Claustrat, Mitra Saadatian-Elahi, Behrouz Kassaï
Affiliations
Randomized Controlled Trial

A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial

Catherine Cornu et al. BMC Complement Altern Med. .

Abstract

Background: To evaluate the effect of a dietary supplement containing polyunsaturated fatty acids, in association with Humulus lupulus extract, on the quality of sleep using the Leeds sleep evaluation questionnaire (LSEQ) in subjects with moderate to severe sleep disorders.

Methods: Randomized placebo-controlled trial, in a Population-based setting. Participants were adult patients 25 to 65 years old with a chronic primary insomnia who volunteered for the study. The tested intervention consisted of two soft gelatine capsules per day, containing either the dietary supplement (active group) or olive oil (placebo group) for a month. Subjects could also volunteer for two ancillary studies on melatonin and actigraphy. Evaluation criteria included i) perception of the quality of sleep at the end of treatment using the LSEQ questionnaire, ii) sleep efficiency measured by one-week actigraphic movement measurement performed before and during the treatment in a subsample of subjects, iii) night melatonin and 6 sulfatoxymelatonin (aMT6S) urine rates in a subsample of subjects.

Results: The average of Leeds score was similar in both groups (p = 0.95). A marked improvement in the quality of sleep was observed in both placebo (62%) and active (65%) group (p = 0.52). The evolution of urinary melatonin, aMT6S, and of the Mel/aMT6S ratio showed no differences between the two groups. Sleep efficiency, as measured by actigraphy, improved similarly in both groups during the treatment period, from 72% to 76% and 75% in the active and placebo group respectively (p = 0.91).

Conclusions: The dietary supplement had neither effect on the perceived quality of sleep, nor on the melatonin metabolism and sleep-wake cycle.

Trial registration: clinical trials.gov:NCT00484497.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study design.
Figure 2
Figure 2
Flow diagram of participants.
Figure 3
Figure 3
Mean score (solid curves and dashed curves) according to age and treatment group for GTS, QOS, AFS and BFW: observed score for each patient are also plotted.
See this image and copyright information in PMC

References

    1. Leger D. Public health and insomnia: economic impact. Sleep. 2000;23(Suppl 3):S69–76. - PubMed
    1. Walsh JK. Clinical and socioeconomic correlates of insomnia. J Clin Psychiatry. 2004;65(Suppl 8):13–9. - PubMed
    1. Buysse DJ. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep. 1994;17(7):630–7. - PubMed
    1. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep. 1999;22(Suppl 2):S394–401. - PubMed
    1. Glass J. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169. doi: 10.1136/bmj.38623.768588.47. - DOI - PMC - PubMed

Publication types

Associated data